Combinazione di metotrexate + infliximab non è superiore all’infliximab da solo nel Crohn
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn’s disease. Feagan BG,…
Approfondisci...
Infliximab + AZA superiore alla monoterapia nella RCU
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Panaccione R, Ghosh S,…
Entero-RM può valutare mucosal healing nel Crohn
Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Ordás I,…
Difosfonati utili nella terapia dell’osteoporosi nei pz affetti da IBD
Efficacy and Safety of Medical Therapy for Low Bone Mineral Density in Patients With Inflammatory Bowel Disease: A Meta-analysis and…
Rischio di K colon in IBD con pouch
Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease. Derikx LA,…
Management delle IBD nell’anziano
Systematic review with meta-analysis: inflammatory bowel disease in the elderlyJ. P. Gisbert, M. Chaparro .Alimentary Pharmacology & Therapeutics Article first…
PCR è predittiva di K colon nell’RCU
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.Rubin DT, Huo D,…
Rischio di cancro nelle IBD sulla base di fenotipo e trattamento
Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study. Jess T, Horváth-Puhó…
Cromoendoscopia nella sorveglianza IBD long standing
Review article: newer optical and digital chromoendoscopy techniques vs. dye-based chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease. G.…
Adalimumab efficace nella prevenzione della recidiva post-chirurgica
Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn’s Disease: A Randomized Controlled Trial. Savarino…
Vedoluzimab nel trattamento del Crohn
Vedolizumab as induction and maintenance therapy for Crohn’s disease. Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE,…
Vedoluzimab nel trattamento della RCU
Vedolizumab as induction and maintenance therapy for ulcerative colitis. Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ,…
Alto rischio di esposizone ai raggi X nei pz con IBD
The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory…
La guarigione mucosa è un end-point cost-effective nel Crohn
Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn’s disease? A decision analysis. Ananthakrishnan AN, Korzenik JR, Hur…
Rischio CCR diminuito in paziente che assumono tiopurine
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.Beaugerie L, Svrcek…
Meta-analisi: infliximab riduce ospedalizzazioni e necessità di chirurgia
Infliximab Reduces Hospitalizations and Surgery Interventions in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Costa J, Magro F,…
Fattori di rischio genetici per infezione da C.difficile in corso di RCU
Genetic risk factors for Clostridium difficile infection in ulcerative colitis.Ananthakrishnan AN, Oxford EC, Nguyen DD, Sauk J, Yajnik V, Xavier…
Infusioni rapide di infliximab sono sicure
Meta-analysis: rapid infliximab infusions are safe .Neef, H. C., Riebschleger, M. P. and Adler, J.Alimentary Pharmacology & Therapeutics *Article first…
Evidenze su efficacia e sicurezza delle diverse formulazioni di 5-ASA
Are There Any Differences in the Efficacy and Safety of Different Formulations of Oral 5-ASA Used for Induction and Maintenance…
Caratteristiche microscopiche per l’iniziale diagnosi di IBD
Microscopic features for initial diagnosis and disease activity evaluation in inflammatory bowel disease.Bressenot A, Geboes K, Vignaud JM, Guéant JL,…
Danno epatico da infliximab
Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases.Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH,…
Meta-analisi sulle infezioni opportunistiche in corso di terapia con biologici
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials.Ford AC, Peyrin-Biroulet L. Am…
Meta-analisi su rischio di tromboembolismo in IBD
Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease.Yuhara H, Steinmaus C, Corley D, Koike J, Igarashi…
Anticorpi anti-IFX determinano perdita di risposta alla terapia : una meta-analisi
Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A…
